Abbott Laboratories stock at EUR 93.23 ahead of the Xetra open
Published on 10/19/2026 at 07:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and market context
- Abbott develops healthcare technologies and offers products including the Lingo glucose system.
- The company’s U.S. home-market context is dated October 19, 2026.
- Abbott Laboratories stock trades pre-market at EUR 93.23 at 7:47 a.m. CEST at Lang & Schwarz on October 19, 2026.
Abbott Laboratories stock is quoted pre-market at EUR 93.23 at 7:47 a.m. CEST at Lang & Schwarz on October 19, 2026. The quote comes ahead of the Xetra open.
Ahead of the Xetra open
The pre-market indication provides the current reference for the stock before the German session begins. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Abbott and the U.S. market
Abbott develops healthcare technologies and offers products including the Lingo glucose system, according to the company’s website, which describes the product’s intended use for adults who are not taking insulin. Abbott is a U.S.-based issuer, making the S&P 500 the applicable benchmark for the home market on October 19, 2026. Market context: Market report S&P 500.
